Drugs are being invented and manufactured right here in the U.S. by Americans, for Americans. So why doesn’t the industry ...

The Trump administration's ever-changing tariffs and Most Favored Nation drug pricing are part of a blizzard of unclear, ...

The announcement by President Donald Trump's administration of the results of a probe into pharmaceutical imports and new ...

Survey responses indicate that bio/pharma faces tariff-driven rising costs and supply strain, with firms aiming to boost compliance and diversification and seeking stable trade and R&D support.

A New Jersey pharmaceutical company filed a lawsuit in federal court last week challenging a new Maine law aimed to protect a ...

The Trump administration has been talking to drugmakers about ways to raise prices of medicines in Europe and elsewhere in ...

The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 billion as branded medicines become subject to a tariff of 15%, analysts said ...

OpenSecrets reports the pharma industry led lobbying in Q2 2025, spending $105.4 million, followed by Ballard Partners at $20 ...

The industry’s reputation surged during the COVID-19 pandemic, according to PatientView’s annual survey of patient groups, peaking two years ago, when 60% of those surveyed said pharma’s ...

What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Santini, Board Member at Collegium Pharmaceutical, a company in the Health Care sector, just ...

The partnership grants Envirotainer exclusive global rights to offer the innovative Swiss Airtainer as part of its full ...

This partnership offers a preview of the future: smarter containers that integrate renewable energy, digital visibility, and lightweight design into one solution.